January 07, 2019
Aprea Therapeutics Announces Presentation at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco
Media
January 07, 2019
Positive results from human PK study assessing Orexo’s new intranasal naloxone formulations for opioid overdose reversal
January 04, 2019
BONESUPPORT appoints Annelie Aava Vikner as Executive Vice President Global Marketing & Communications
January 04, 2019
Rainier Therapeutics Expands Leadership Team to Prepare for Late-Stage Clinical Trials
January 02, 2019
Nordic Nanovector appoints Mark Wright as Head of Manufacturing
December 19, 2018
Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN™ (macimorelin) in the United States and Canada
December 18, 2018
MIPS advances to Nasdaq Stockholms Mid Cap segment
December 13, 2018
Altimmune Announces Clinical Program Updates and Plans for Pipeline Expansion
December 13, 2018
Oncopeptides Capital Markets Day December 14th in New York
December 13, 2018
Orexo regains rights to Zubsolv® in all countries outside the US
